Search results
Results from the WOW.Com Content Network
The hospital was founded in March 1964. It is a Level III Class A hospital (the highest rank in China) and the largest integrated cancer center in southern China for care, research, education and prevention. [1] SYSUCC is ranked among the top three cancer center's in China, [2] [3] and is one of the best in Asia. [4]
The Fudan University Shanghai Cancer Center (FUSCC, Chinese: 复旦大学附属肿瘤医院), also called the Shanghai Cancer Hospital (Chinese: 上海市肿瘤医院), is a teaching hospital affiliated with the Shanghai Medical College of Fudan University. Founded in 1931, it is the first cancer specialty hospital in China.
Lanzhou People's Hospital Number 3, Lanzhou [4] Lanzhou Heavy Ion Cancer Treatment Center, Lanzhou (joint venture by Sheng De Group, the city government and Chinese Academy of Sciences, Lanzhou Branch, Institution of Modern Physics) Lanzhou Military Hospital, Lanzhou; People's Hospital of Gansu; Wuwei People's Hospital, Wuwei
In 1977, the Institute of Cancer Research was established with eight departments. The institute is dedicated to cancer research, treatment, and prevention. The institute was established by Professor Jin Xianzhai, a prominent Chinese oncologist, it originated as the Cancer Prevention Research Laboratory within Tianjin People's Hospital.
The FDA is working with a Chinese drugmaker to import cisplatin, a cancer drug in shortage in the U.S that's used in 10% to 20% of cancer patients' chemotherapy.
Peking University International Hospital (Chinese: 北大国际医院; pinyin: běidàguójìyīyuàn) is a non-profit hospital affiliated with Peking University.It is a combination of medicare, teaching and research to be in line with the international practices, that provides medical services for patients covered by Beijing social medical insurance, commercial insurance, public medicare and ...
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
A cancer cell therapy from CSPC Pharmaceutical Group that uses synthetic messenger RNA (mRNA) technology has received regulatory clearance in China for human clinical trial, the Chinese drugmaker ...